Business Description
AIM Vaccine Co Ltd
ISIN : CNE100005KF2
Share Class Description:
HKSE:06660: Class HTotal Employee Number:
1,466Compare
Compare
Traded in other countries / regions
06660.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2022-10-06Description
AIM Vaccine Co Ltd is a China-based full-chain vaccine company engaged in the research and development, manufacturing, and commercialization of vaccine products. The company's commercialized products include recombinant HBV vaccines, freeze-dried human rabies vaccines, inactivated HAV vaccines, Group A, C, Y, and W135 meningococcal polysaccharide vaccines, bivalent inactivated HFRS vaccines, and mumps vaccines. The company generates the majority of its revenue from the PRC.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.67 | |||||
Debt-to-EBITDA | -3.48 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.06 | |||||
Beneish M-Score | -2.88 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.6 | |||||
3-Year EBITDA Growth Rate | -30.2 | |||||
3-Year EPS without NRI Growth Rate | 18.7 | |||||
3-Year FCF Growth Rate | 44.3 | |||||
3-Year Book Growth Rate | -18.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.34 | |||||
9-Day RSI | 47.66 | |||||
14-Day RSI | 50.2 | |||||
3-1 Month Momentum % | -27.33 | |||||
6-1 Month Momentum % | -46.39 | |||||
12-1 Month Momentum % | -64.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.61 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 414.24 | |||||
Days Sales Outstanding | 439.42 | |||||
Days Payable | 85.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | -1.89 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 66.43 | |||||
Operating Margin % | -17.84 | |||||
Net Margin % | -66.1 | |||||
EBITDA Margin % | -52.35 | |||||
FCF Margin % | -5.42 | |||||
OCF Margin % | 16.24 | |||||
ROE % | -22.97 | |||||
ROA % | -9.95 | |||||
ROIC % | -2.9 | |||||
3-Year ROIIC % | -1.19 | |||||
ROC (Joel Greenblatt) % | -20.71 | |||||
ROCE % | -18.86 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 1.2 | |||||
PS Ratio | 1.85 | |||||
PB Ratio | 0.68 | |||||
Price-to-Tangible-Book | 1.26 | |||||
Price-to-Operating-Cash-Flow | 11.38 | |||||
EV-to-EBIT | -5.41 | |||||
EV-to-EBITDA | -7.02 | |||||
EV-to-Revenue | 3.67 | |||||
EV-to-FCF | -67.73 | |||||
Price-to-GF-Value | 0.42 | |||||
Earnings Yield (Greenblatt) % | -18.48 | |||||
FCF Yield % | -2.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AIM Vaccine Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,124.779 | ||
| EPS (TTM) (HK$) | -0.602 | ||
| Beta | 2.1449 | ||
| 3-Year Sharpe Ratio | -0.85 | ||
| 3-Year Sortino Ratio | -1.15 | ||
| Volatility % | 42.77 | ||
| 14-Day RSI | 50.2 | ||
| 14-Day ATR (HK$) | 0.136648 | ||
| 20-Day SMA (HK$) | 1.6955 | ||
| 12-1 Month Momentum % | -64.84 | ||
| 52-Week Range (HK$) | 1.2 - 4.8 | ||
| Shares Outstanding (Mil) | 1,226.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AIM Vaccine Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AIM Vaccine Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
AIM Vaccine Co Ltd Frequently Asked Questions
What is AIM Vaccine Co Ltd(HKSE:06660)'s stock price today?
The current price of HKSE:06660 is HK$1.70. The 52 week high of HKSE:06660 is HK$4.80 and 52 week low is HK$1.20.
When is next earnings date of AIM Vaccine Co Ltd(HKSE:06660)?
The next earnings date of AIM Vaccine Co Ltd(HKSE:06660) is .
Does AIM Vaccine Co Ltd(HKSE:06660) pay dividends? If so, how much?
AIM Vaccine Co Ltd(HKSE:06660) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers